Article
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Blood advances - 23 Jan 2018
Drazer Michael W, Kadri Sabah, Sukhanova Madina, Patil Sushant A, West Allison H, Feurstein Simone, Calderon Dalein A, Jones Matthew F, Weipert Caroline M, Daugherty Christopher K, Ceballos-López Adrián A, Raca Gordana, Lingen Mark W, Li Zejuan, Segal Jeremy P, Churpek Jane E, Godley Lucy A
Abstract excerpt
Next-generation sequencing (NGS)-based targeted gene capture panels are used to profile hematopoietic malignancies to guide prognostication and treatment decisions. Because these panels include genes associated with hereditary hematopoietic malignancies (HHMs), we hypothesized that these panels could identify pathogenic germ line variants in malignant cells, thereby identifying patients at risk for HHMs. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.